Ameriprise Financial Inc Provention Bio, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $2.76 Million - $9.98 Million	412,127 New	412,127 $9.93 Million
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $190,094 - $312,763	-28,330 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $4,321 - $8,305	-427 Reduced 1.48%	28,330 $298,000
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $31,125 - $50,001	2,640 Added 10.11%	28,757 $488,000
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $13,752 - $20,216	1,330 Added 5.37%	26,117 $335,000
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $193,586 - $421,379	24,787 New	24,787 $350,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.